Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin topical gel versus placebo as adjunctive pain treatment after stroke
IRCT20120215009014N559Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of silymarin in Post-stroke pain (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Mean pain score, Mean quality of life score and 1 more. Started Aug 2025; status: completed.
02
Drugs
silymarin
03
Conditions
Post-stroke pain
Beyond the preview
Go deeper on IRCT20120215009014N559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N559.